ID: ALA3964918

Max Phase: Preclinical

Molecular Formula: C17H16Cl2N2OS

Molecular Weight: 367.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc2c1N(C(=O)CSc1ncc(Cl)cc1Cl)CCC2

Standard InChI:  InChI=1S/C17H16Cl2N2OS/c1-11-4-2-5-12-6-3-7-21(16(11)12)15(22)10-23-17-14(19)8-13(18)9-20-17/h2,4-5,8-9H,3,6-7,10H2,1H3

Standard InChI Key:  FLTBYMGWJOPCBI-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily V member 3 542 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 367.30Molecular Weight (Monoisotopic): 366.0360AlogP: 4.77#Rotatable Bonds: 3
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.65CX LogD: 4.65
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.73Np Likeness Score: -2.03

References

1.  (2015)  Compounds of modulating TRPV3 function, 

Source

Source(1):